Mardi Dier
Chief Financial Officer
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Madrigal Pharmaceuticals, Inc. (MDGL) | Executive Vice President and Chief Financial Officer | $566,042 | $6,085,089 |
| 2024 | Madrigal Pharmaceuticals, Inc. (MDGL) | Executive Vice President and Chief Financial Officer | $464,679 | $8,751,912 |
| 2022 | Ultragenyx Pharmaceutical Inc. (RARE) | Former Chief Financial Officer and Executive Vice President | $607,346 | $4,436,756 |
| 2021 | Ultragenyx Pharmaceutical Inc. (RARE) | Former Chief Financial Officer and Executive Vice President | $561,539 | $3,331,874 |
| 2020 | Ultragenyx Pharmaceutical Inc. (RARE) | Former Chief Financial Officer and Executive Vice President | $116,346 | $6,120,642 |
Executive changes
-
Resigned Executive Vice President and Chief Financial Officer at Ultragenyx Pharmaceutical Inc. (RARE)2022-11-15
Earnings-call appearances
-
Q2 2026 Earnings Call2026-07-30
Madrigal Pharmaceuticals, Inc. (MDGL)
-
Madrigal Pharmaceuticals, Inc. Q1 FY2026 Earnings Call2026-05-06
Madrigal Pharmaceuticals, Inc. (MDGL)
-
TD Cowen 46th Annual Health Care Conference2026-03-03
Madrigal Pharmaceuticals, Inc. (MDGL)
-
Madrigal Pharmaceuticals, Inc. Q4 FY2025 Earnings Call2026-02-19
Madrigal Pharmaceuticals, Inc. (MDGL)
-
Madrigal Pharmaceuticals, Inc. Q3 FY2025 Earnings Call2025-11-04
Madrigal Pharmaceuticals, Inc. (MDGL)
-
Madrigal Pharmaceuticals, Inc. Q2 FY2025 Earnings Call2025-08-05
Madrigal Pharmaceuticals, Inc. (MDGL)
-
Madrigal Pharmaceuticals, Inc. Q1 FY2025 Earnings Call2025-05-01
Madrigal Pharmaceuticals, Inc. (MDGL)
-
Madrigal Pharmaceuticals, Inc. Q4 FY2024 Earnings Call2025-02-26
Madrigal Pharmaceuticals, Inc. (MDGL)
-
Madrigal Pharmaceuticals, Inc. Q3 FY2024 Earnings Call2024-10-31
Madrigal Pharmaceuticals, Inc. (MDGL)
-
Madrigal Pharmaceuticals, Inc. Q2 FY2024 Earnings Call2024-08-07
Madrigal Pharmaceuticals, Inc. (MDGL)
-
Madrigal Pharmaceuticals, Inc. Q1 FY2024 Earnings Call2024-05-07
Madrigal Pharmaceuticals, Inc. (MDGL)
-
Ultragenyx Pharmaceutical Inc. Q3 FY2022 Earnings Call2022-11-02
Ultragenyx Pharmaceutical Inc. (RARE)
-
Ultragenyx Pharmaceutical Inc. Q2 FY2022 Earnings Call2022-07-28
Ultragenyx Pharmaceutical Inc. (RARE)
-
Ultragenyx Pharmaceutical Inc. Q1 FY2022 Earnings Call2022-05-05
Ultragenyx Pharmaceutical Inc. (RARE)
-
Ultragenyx Pharmaceutical Inc. Q4 FY2021 Earnings Call2022-01-10
Ultragenyx Pharmaceutical Inc. (RARE)
-
Ultragenyx Pharmaceutical Inc. Q3 FY2021 Earnings Call2021-11-02
Ultragenyx Pharmaceutical Inc. (RARE)
-
Ultragenyx Pharmaceutical Inc. Q1 FY2021 Earnings Call2021-05-04
Ultragenyx Pharmaceutical Inc. (RARE)
-
Ultragenyx Pharmaceutical Inc. Q4 FY2020 Earnings Call2021-02-11
Ultragenyx Pharmaceutical Inc. (RARE)
-
Ultragenyx Pharmaceutical Inc. Q3 FY2020 Earnings Call2020-10-27
Ultragenyx Pharmaceutical Inc. (RARE)